Predict your next investment

Earlybird.io company logo
MOBILE & TELECOMMUNICATIONS | Mobile Software & Services / Health & Wellness
earlybird.io

See what CB Insights has to offer

Founded Year

2019

Stage

Seed VC | Alive

Total Raised

$2.4M

Last Raised

$2.4M | 1 yr ago

About Earlybird.io

Earlybird.io exploits finger interactions with personal electronics to generate a novel biometric signal to identify subtle motor decline.

Earlybird.io Headquarter Location

Chicago, Illinois, 60622,

United States

224-706-0232

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Earlybird.io

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Earlybird.io is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

7,884 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

D

Digital Health

11,676 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Earlybird.io Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Earlybird.io Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.